Latest News

Lavipharm (ATH:LAVI) has had a great run on the share market with its stock up by a significant 47% over the last three...

When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...

CapitaLand Integrated Commercial Trust (SGX:C38U) has drawn fresh investor attention after its manager announced that a consortium it participates in has secured a mixed-use Hougang Central site tender worth about S$1.5b. See our latest analysis for CapitaLand Integrated Commercial Trust. Despite the size of this Hougang Central project, CapitaLand Integrated Commercial Trust’s recent share price moves have been fairly muted, with a 7 day share price return of 1.67% decline and a year to date...

Exelon stock triggered review With no single event driving Exelon (EXC) into focus, investors may be looking at its recent share performance and financial profile to reassess how this regulated utility fits into a diversified portfolio. See our latest analysis for Exelon. At a share price of US$44.55, Exelon has seen a 2.3% 1 month share price return but a 6.6% 3 month share price decline, while its 1 year total shareholder return of 13.4% points to steadier, income supported progress for...

Why Globant stock is attracting fresh attention With no single headline event driving Globant (GLOB) today, investors are instead focusing on how its current share price of US$69.19 lines up with recent returns and the company’s reported fundamentals. See our latest analysis for Globant. Globant’s recent 1-day, 7-day and 90-day share price returns of 0.22%, 1.45% and 13.84% suggest some short term momentum, although the 1-year total shareholder return of a 66.67% loss shows longer term...

If you are wondering whether Rio Tinto Group’s current share price lines up with its underlying value, you are not alone. This article is built to unpack exactly that question in a clear, practical way. Rio Tinto’s share price closed at £66.76, with returns of 5.3% over 7 days, 11.6% over 30 days, 11.5% year to date, 44.7% over 1 year, 27.6% over 3 years and 77.5% over 5 years, which has naturally put more attention on what you are actually paying for today. Alongside these share price...

Viatris Inc. recently launched Inpefa (sotagliflozin) in the United Arab Emirates, its first commercialization of the heart failure treatment in its territories outside the U.S. and Europe, following an exclusive licensing deal with Lexicon Pharmaceuticals for markets beyond those regions. This marks Viatris’ first international rollout of a dual SGLT1/2 inhibitor for cardiovascular disease, highlighting an effort to broaden its innovative portfolio and expand patient access in key markets...

Why Plains GP Holdings (PAGP) is on investors’ radar Plains GP Holdings (PAGP) has caught attention after a strong past 3 months, with the stock showing a month-long gain as well and meaningful multi year total returns that invite closer scrutiny. See our latest analysis for Plains GP Holdings. At a share price of US$20.42, Plains GP Holdings has recently seen a 30 day share price return of 8.5% and a 90 day share price return of 15.6%. Its 5 year total shareholder return of 233.9% points to...

Earlier this month, ASM International reported an upbeat early Q4 2025 update, indicating that Q1 2026 revenue at constant currencies should rise healthily, supported by demand from leading-edge foundry and logic customers. Berenberg responded by upgrading its medium-term forecasts for ASM International’s sales, EBIT, and EPS, highlighting the importance of steadier capital spending signals from major customers such as TSMC and Intel for the company’s order outlook. We will now examine how...

Event context and recent stock performance Booz Allen Hamilton Holding (BAH) has drawn investor attention after recent trading moves, with the stock showing mixed short term returns, including a 0.1% gain over the past month and a 9.8% rise over the past 3 months. See our latest analysis for Booz Allen Hamilton Holding. At a share price of $93.93, Booz Allen Hamilton Holding has seen a 10.0% 1 month share price return and a 10.65% year to date share price return. However, its 1 year total...

Docebo (TSX:DCBO) is back on investor radars after launching a credit-based pricing model for its AI-powered modules and securing new enterprise wins, along with deeper usage within large existing customers. See our latest analysis for Docebo. That product progress and recent analyst attention come against a weak share price backdrop, with a 30 day share price return of a 14.15% decline and a 1 year total shareholder return of a 58.02% decline. This suggests momentum has been fading even as...

Wondering if Global Business Travel Group at US$7.15 is offering value or just extra risk right now? This article walks through what the current price actually implies. The stock has seen a 6% decline over the last week, 8.2% over the last month, and sits 18.9% lower over the past year, with a small 1.4% gain over three years. Recent coverage has focused on Global Business Travel Group as a listed play on corporate and managed travel, with attention on how its scale and business model...

If you are wondering whether BioNTech's current share price lines up with its underlying value, this article will walk you through the key pieces that matter most. BioNTech shares last closed at US$118.0, with returns of 8.3% over 7 days, 24.8% over 30 days and 22.0% year to date, while the 1 year, 3 year and 5 year returns were a 1.5% decline, 16.0% decline and 2.6% respectively. Recent news flow around BioNTech has focused on its position in the pharmaceuticals and biotech space, including...

Why Warby Parker stock is back in focus Warby Parker (WRBY) is drawing fresh attention after its latest quarter paired 15.2% year on year revenue growth and an earnings per share beat with softer full year revenue guidance. See our latest analysis for Warby Parker. That mix of strong quarterly growth and softer guidance has been reflected in the share price, with the stock at $27.38 after a 29.58% 90 day share price return and a 71.88% three year total shareholder return, though near term...

Why THK Stock Is on Investors’ Radar THK (TSE:6481) has drawn attention after recent share price moves, including a 2.4% decline over the last day and positive returns over the past week, month, and past 3 months. For investors tracking industrial automation and precision components, those short term swings sit alongside a 1 year total return of 19.9% and a 3 year total return that is described as very large, supported by reported revenue of ¥355,856 and net income of ¥6,503. See our latest...

Keurig Dr Pepper (KDP) has been in focus after acquiring a majority stake in GHOST Energy, a move tied to CEO Tim Cofer’s Now and Next plan to target younger consumers and reshape the beverage portfolio. See our latest analysis for Keurig Dr Pepper. Despite the buzz around GHOST Energy and a high profile TikTok campaign for Dr Pepper, Keurig Dr Pepper’s recent share price performance has been subdued, with a 90 day share price return of a 3.99% decline and a 1 year total shareholder return of...

If you are wondering whether SentinelOne's share price reflects its true worth today, you are not alone. Many investors are asking the same question. The stock last closed at US$14.56, with a 4.7% gain over the past week but a 37.4% decline over the last year. This can change how the market views both its growth potential and its risk. Recent headlines around SentinelOne have focused on its role in cybersecurity and how investors are reassessing software names more broadly. This helps...

It is hard to get excited after looking at Kanpur Plastipack's (NSE:KANPRPLA) recent performance, when its stock has...

If you are wondering whether Manulife Financial's current share price lines up with its underlying value, you are not alone. The stock last closed at C$50.89, with a 2.4% decline over the past 7 days, a 1.5% gain over 30 days, a 2.2% gain year to date, a 21.4% return over 1 year and a 124.2% return over 3 years, while the 5 year return is very large. Recent attention on Manulife Financial has been shaped by ongoing discussion around large insurers, interest rate expectations and how...

Daktronics (NasdaqGS:DAKT) announced that Corporate Secretary and Vice President of Human Resources, Carla S. Gatzke, is leaving the company. Her departure affects leadership oversight of human resources and corporate governance functions. Daktronics focuses on electronic scoreboards, large video displays, and digital signage used in sports venues, transportation, and commercial settings. For you as an investor, a change in senior human resources leadership touches on how the company...

Context for JBS (JBS) after recent share moves JBS (JBS) has drawn fresh attention after a recent pullback of about 0.6% in the latest session, alongside gains of roughly 5.9% over the past week and 6.7% over the past month. See our latest analysis for JBS. At a share price of US$15.53, JBS sits on a 90 day share price return of 17.56% and a year to date share price return of 9.52%, suggesting momentum has been building in recent months as investors reassess its risk and growth profile. If...

If you are wondering whether TJX Companies at about US$150 a share still offers value, you are not alone, especially after such a strong long term return profile. The stock is down about 4.6% over the last week and 4.5% over the last month, while it is still up 21.6% over 1 year, 91.9% over 3 years and 152.3% over 5 years. Recent headlines around TJX have focused on its position as a large off price retailer and its role as a major player in U.S. retail. This has kept investor attention on...

In January 2026, China Petroleum & Chemical Corporation reported its 2025 operating results, showing slightly higher crude oil and natural gas production but lower refinery throughput and reduced gasoline and diesel output compared with the prior year. An interesting shift emerged in the product mix, with jet-fuel-related kerosene, light chemical feedstocks, ethylene, and synthetic resins all increasing, while domestic refined oil product sales volumes declined. We’ll now examine how this...

SM Energy recently drew attention after Zacks assigned it a Rank #5 (Strong Sell), following a decline in consensus earnings estimates that raised questions about its near-term earnings outlook. At the same time, SM Energy’s shares are trading at a discount to peers, creating an unusual mix of weaker earnings expectations and apparently cheaper valuation. With this context in mind, we’ll explore how weaker earnings estimates may influence SM Energy’s investment narrative for investors. The...